BioCardia, Inc.BCDANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR+6.6%
5Y CAGR+5.9%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
+6.6%/yr
Annual compound
5Y CAGR
+5.9%/yr
Consistent
Percentile
P64
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202419.53%
20235.56%
2022-1.88%
202116.11%
2020-30.83%
201914.67%
2018-27.66%
2017-57.03%
2016-1768.28%
201554.67%